SpringWorks Therapeutics, Inc. Quarterly Depreciation in USD from Q4 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
SpringWorks Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from Q4 2017 to Q1 2023.
  • SpringWorks Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $253K, a 134% increase year-over-year.
  • SpringWorks Therapeutics, Inc. annual Depreciation for 2023 was $1.6M, a 100% increase from 2022.
  • SpringWorks Therapeutics, Inc. annual Depreciation for 2022 was $800K, a 60% increase from 2021.
  • SpringWorks Therapeutics, Inc. annual Depreciation for 2021 was $500K, a 43.3% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $253K +$145K +134% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q1 2022 $108K -$2K -1.82% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $110K +$40K +57.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $70K +$49K +233% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $21K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2017 $3K Aug 18, 2017 Dec 31, 2017 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.